Why one dose does not fit all
Everything so far described populations. But the curve that matters for treatment is the one inside the single patient in the room — and because of biological variability, their personal minimum effective concentration and their personal toxicity threshold can sit well to the left or right of the textbook average. Age, kidney and liver function, body size, other drugs, and genetics all shift the picture. This is the heart of why special populations like children and the elderly so often need different doses.
So instead of trusting one fixed dose, clinicians often use dose titration: start cautiously, observe, and adjust in steps until the patient reaches the sweet spot between 'not enough' and 'too much' — their personal slice of the therapeutic window.
How titration actually works
- Start low. Begin at or below the usual starting dose, especially in special populations, to stay clear of the toxic edge while you learn how this patient responds.
- Wait for steady state. Before judging a dose, let blood levels settle; effects measured before steady state understate where the dose will eventually land.
- Assess both ends. Check the wanted effect AND watch for any adverse drug reaction. Titration is steered by both benefit and harm, not benefit alone.
- Step up — or stop. If effect is too small and the patient tolerates it, raise the dose by a measured increment and repeat. If you reach the ceiling effect or hit side effects, do not keep climbing.
When numbers help and when judgement rules
For some drugs the effect is easy to see directly — pain eases, blood pressure falls — and you titrate to the visible response. For narrow-window drugs whose effect or toxicity is hard to read at the bedside, you titrate using therapeutic drug monitoring, aiming the blood level squarely inside the target band rather than guessing from symptoms.
Either way, titration ties this whole track together. The dose–response curve told us effect climbs then ceilings; the 50% doses gave us landmarks; the index and window told us how much room we have; potency versus efficacy told us what raising the dose can and cannot buy. Titration is where all of that meets one real person, one careful step at a time, with the goal of landing them safely and lastingly inside their own therapeutic window — without ever wandering toward the maximum tolerated dose.